Case Report: Synchronous ALK-positive laryngeal inflammatory myofibroblastic tumor and EGFR-mutant lung adenocarcinoma in a child
Frontiers in Pediatrics · 06.08.2026 · 14
DOI: 10.3389/fped.2026.1874110 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 06.08.2026. Verfasst von Guodun Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The concurrent occurrence of two histogenetically distinct tumors in a child is exceptionally uncommon and may create substantial diagnostic uncertainty. To the best of our knowledge, this is the first reported case of synchronous diagnosis of an ALK-rearranged inflammatory myofibroblastic tumor (IMT) of the larynx and EGFR-mutant lung adenocarcinoma. A 7-year-old boy presented with dyspnea and hoarseness. A laryngeal mass was resected and confirmed to be ALK-positive IMT harboring a THBS1-ALK rearrangement. PET-CT also detected a solitary lung nodule in the right lower lobe, which was initially considered possible metastatic IMT. However, serial chest CT over 22 months demonstrated only minimal, indolent enlargement, a pattern that was inconsistent with the expected behavior of metastatic disease. Because of this clinicoradiologic discrepancy, thoracoscopic wedge resection was performed for definitive diagnosis. Histopathology revealed acinar-predominant invasive adenocarcinoma of the lung that was positive for TTF-1, and Napsin A, and negative for ALK. Next-generation sequencing identified an EGFR exon 20 insertion (p.N771_P772insG) and a low tumor mutational burden. The discordant clinical behavior, isolated and indolent radiologic evolution, divergent histopathologic and immunophenotypic profiles, and distinct oncogenic drivers collectively supported a diagnosis of synchronous primary tumors rather than metastatic IMT. Because sequencing was limited to the DICER1 hotspot region, other hereditary cancer-predisposition mechanisms could not be definitively excluded. This case underscores the importance of longitudinal imaging, integrated pathology, and molecular profiling when presumed metastatic disease follows an atypical course pediatric oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Zitieren
APA
Zheng, G., Luo, D., He, T., Yuan, M., Yang, G., Dai, S., & Xu, C. (2026). Case Report: Synchronous ALK-positive laryngeal inflammatory myofibroblastic tumor and EGFR-mutant lung adenocarcinoma in a child. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1874110
Vancouver
Zheng G, Luo D, He T, Yuan M, Yang G, Dai S, et al. Case Report: Synchronous ALK-positive laryngeal inflammatory myofibroblastic tumor and EGFR-mutant lung adenocarcinoma in a child. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1874110
BibTeX
@article{Zheng2026,
author = {Zheng, Guodun and Luo, Dengke and He, Taozhen and Yuan, Miao and Yang, Gang and Dai, Shiyi and Xu, Chang},
title = {Case Report: Synchronous ALK-positive laryngeal inflammatory myofibroblastic tumor and EGFR-mutant lung adenocarcinoma in a child},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1874110}
}
EUVIMED